REGENERON PHARMACEUTICALS, INC. Insider Trading for September 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. for September 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 06 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Option Exercise | M | 272.70 | 3,000 | 818,100 | 57,000 | |
Sep 06 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Sell | S | 499.69 | 100 | 49,969 | 7,099 | 7.2 K to 7.1 K (-1.39 %) |
Sep 06 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Sell | S | 498.25 | 100 | 49,825 | 7,199 | 7.3 K to 7.2 K (-1.37 %) |
Sep 06 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Sell | S | 496.86 | 100 | 49,686 | 7,299 | 7.4 K to 7.3 K (-1.35 %) |
Sep 06 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Sell | S | 496.52 | 74 | 36,742 | 7,399 | 7.5 K to 7.4 K (-0.99 %) |
Sep 06 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Sell | S | 496.51 | 100 | 49,651 | 7,473 | 7.6 K to 7.5 K (-1.32 %) |
Sep 06 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Sell | S | 501.88 | 89 | 44,667 | 7,573 | 7.7 K to 7.6 K (-1.16 %) |
Sep 06 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Sell | S | 500.33 | 100 | 50,033 | 7,662 | 7.8 K to 7.7 K (-1.29 %) |
Sep 06 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Payment of Exercise | F | 501.29 | 706 | 353,911 | 7,762 | 8.5 K to 7.8 K (-8.34 %) |
Sep 06 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Payment of Exercise | F | 501.29 | 1,631 | 817,604 | 8,468 | 10.1 K to 8.5 K (-16.15 %) |
Sep 06 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Buy | M | 272.70 | 3,000 | 818,100 | 10,099 | 7.1 K to 10.1 K (+42.26 %) |
Sep 01 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Option Exercise | M | 272.70 | 2,000 | 545,400 | 60,000 | |
Sep 01 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Sell | S | 497.69 | 127 | 63,207 | 7,099 | 7.2 K to 7.1 K (-1.76 %) |
Sep 01 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Sell | S | 497.42 | 100 | 49,742 | 7,226 | 7.3 K to 7.2 K (-1.37 %) |
Sep 01 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Sell | S | 489.56 | 100 | 48,956 | 7,326 | 7.4 K to 7.3 K (-1.35 %) |
Sep 01 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Sell | S | 487.88 | 100 | 48,788 | 7,426 | 7.5 K to 7.4 K (-1.33 %) |
Sep 01 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Payment of Exercise | F | 486.91 | 454 | 221,057 | 7,526 | 8 K to 7.5 K (-5.69 %) |
Sep 01 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Payment of Exercise | F | 486.91 | 1,119 | 544,852 | 7,980 | 9.1 K to 8 K (-12.30 %) |
Sep 01 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Buy | M | 272.70 | 2,000 | 545,400 | 9,099 | 7.1 K to 9.1 K (+28.17 %) |